The Latest from

March 14, 2023

These bank runs aren’t as they seem

...Read More
March 7, 2023

This materials company is collecting all the Capex

...Read More
February 28, 2023

This chip manufacturer gets lost in the shuffle

...Read More
February 21, 2023

The social media company shows signs of recovery after big losses

...Read More
February 14, 2023

The high spending on research worked out and unlocked high profitability for this pharmaceutical company

...Read More
February 7, 2023

This company is one of the few housing players that benefits from higher mortgage rates

...Read More
January 31, 2023

The market punishes this pharmaceutical company unfairly along with the rest of the sector

...Read More
January 24, 2023

Supply chains are finally improving, a game changer for this wire business

...Read More
January 17, 2023

This supply chain gem is hidden by the as-reported metrics

...Read More
January 10, 2023

This healthcare equipment company enjoys high demand as people see themselves more on camera

...Read More
January 3, 2023

The market is pricing the wrong geopolitical risks, resulting in the undervaluation of this semiconductor business

...Read More
December 20, 2022

This biotech name gets the attention it deserves from the biggest players in the space

...Read More
December 13, 2022

This secret power behind the famous pharmaceuticals continues to enjoy high profitability

...Read More
December 6, 2022

The U.S. is investing in infrastructure, and this key commodity is in high demand

...Read More
November 29, 2022

The market cannot differentiate between homebuilders and other construction companies, making this stock undervalued

...Read More
November 22, 2022

This asset management firm proves that active management isn’t dead

...Read More
November 15, 2022

Replacing the new with the old to keep the lights on

...Read More
November 8, 2022

This company is helping get our hygiene back to its pre-pandemic self

...Read More
November 1, 2022

This staffing firm will help keep hospitals full post-pandemic

...Read More
October 25, 2022

This life sciences company quietly continues to profit from mRNA, as Moderna takes all the attention

...Read More

Subscriptions & Services

Market Phase Cycle

Even the best stock-pickers can lose money in bear markets. Our Market Phase Cycle monthly newsletter gives investors access to in-depth macroeconomic...

Learn More

All Valens Research Newsletters

Our newsletters highlight the most compelling research the Valens team has written over the prior week. This includes Valens’ top picks for credit and equity, management sentiment trends, and aggregate trends in corporate valuation...

Learn More

UAFRS Database and App Access

Our database of 25,000+ companies, each with manual adjustments to uncover more economically accurate, and comparable corporate performance. Investors can make better investment decisions with better data and better tools...

Learn More

Institutional Services

Access to all of Valens Research’s offerings, including newsletters and database access, plus custom solutions for your institution and a dedicated team of analysts to tailor UAFRS and Valens’ tools for your firm’s specific financial analytics needs...

Learn More

About Us
Valens Research is a global investment services firm with research powered by the proprietary UAFRS framework. The firm offers no-nonsense opinions and recommendations, industry expertise, and proven, back-tested data, with offices worldwide.

Sign up for FA Alpha Daily

Resources

The Latest from

Please fill out the fields below so that our client relations team can contact you

Please leave us your contact details so we can reach out to you as soon as we can.

Request A Demo

The Latest from

Please fill out the fields below so that our client relations team can contact you